Inhibikase Therapeutics Inc. (IKT) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Inhibikase Therapeutics I...

    NASDAQ: IKT · Real-Time Price · USD
    1.67
    -0.04 (-2.34%)
    At close: Sep 05, 2025, 3:59 PM
    1.67
    0.00%
    After-hours: Sep 05, 2025, 04:41 PM EDT

    Inhibikase Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -2.8 -0.36 -0.7 -1.81
    PEG Ratio
    		 0.04 0.02 0.06 -0.01
    PS Ratio
    		 n/a 26.00 102.12 8.63
    PB Ratio
    		 0.81 0.62 0.60 0.70
    P/FCF Ratio
    		 -4.02 -0.37 -0.72 -1.87
    P/OCF Ratio
    		 -4.02 -0.37 -0.73 -1.87
    OCF/S Ratio
    		 n/a -69.42 -140.56 -4.61
    Debt / Equity Ratio
    		 0.00 0.06 0.02 0.01
    Quick Ratio
    		 26.37 4.13 6.29 10.45
    Current Ratio
    		 26.37 4.13 6.59 10.47
    Asset Turnover
    		 n/a 0.02 0.00 0.07
    Interest Coverage
    		 n/a n/a -243.49 -741.16
    Return on Equity
    		 -0.29 -1.73 -0.85 -0.39
    Return on Assets
    		 -0.28 -1.31 -0.72 -0.35
    Return on Invested Capital
    		 -0.3 -1.73 -0.83 -0.38
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a -51.28 0.95 -2.66
    Net Profit Margin
    		 n/a -73.05 -145.05 -4.78
    Pretax Profit Margin
    		 n/a -73.05 -146.26 -4.77
    Operating Profit Margin
    		 n/a -77.12 -146.86 -4.76
    FCF Margin
    		 n/a n/a n/a n/a
    EBITDA Margin
    		 n/a -76.44 -146.81 -4.76

    Add to Watchlist